Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 to 64

Exploring the Temporo-masseteric Nerve Block in Healthy Volunteers

Official title: Non-randomized Pilot Study to Characterize Temporo-masseteric Nerve Block (TMNB) in

Run by Rutgers, The State University of New Jersey · NCT05507164 · Data updated 2026-11-12

This study is testing how a specific nerve block injection affects muscle activity and bite strength in healthy volunteers to see if it can help with pain relief.

More Large Vessel Occlusion trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 64 Years
SexAll
Enrollment20 (estimated)
SponsorRutgers, The State University of New Jersey
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Newark, New Jersey)
StatusRecruiting
StartedOctober 10, 2022
Main results expectedSeptember 2026
Study endsDecember 2026
Registry record updatedDecember 5, 2025
Trial IDNCT05507164 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adults aged 18-64 who have no history of temporomandibular disorders or significant orofacial pain.

Probably not a fit

Patients with a history of temporomandibular disorders, significant orofacial pain, or those currently undergoing orthodontic treatment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study aims to characterize the Temporo-masseteric Nerve Block (TMNB) injection in 20 healthy volunteers. It will assess bite-force distribution and surface electromyographic activity of the temporalis and masseter muscles before and after the TMNB injection. Evaluations will occur at 30 minutes, 2 hours, and 2 weeks post-injection, with participants also providing feedback on their experience. The study seeks to understand the TMNB's effects on muscle activity and its potential for sustained pain relief.

Why it matters

Potential benefit: If successful, this study could enhance understanding of TMNB's effectiveness in managing myogenous pain, potentially leading to improved treatment options.

How similar studies have gone: While the TMNB approach is emerging, similar nerve blocks have shown promise in pain management, suggesting potential for success in this novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18-64 years of age
* All ethnicity
* Male and female sex
* Fluent in written/spoken English
* Never been diagnosed with TMD
* No significant history of orofacial pain
* \<5 headaches/month in the 3 months before enrollment
* No reported use of a nightguard or occlusal splint 'No' to all questions on self-administered questionnaire for TMD screening:
* Pain in jaw or temple on either side of the face in the last 30 days
* Stiffness or pain in jaw upon awakening in the last 30 days
* Any pain increase/reduction in the jaw/temple region during the last 30 days with

  * Chewing hard or tough food
  * Opening mouth or moving jaw forward or to the side
  * Hold teeth together/clenching/grinding/chewing gum
  * Using the jaw during activities such as talking, kissing or yawning

Exclusion Criteria:

* Traumatic injury/ surgery on face or jaw \< 6 months
* current orthodontic treatment
* pregnant or nursing,
* kidney failure or renal dialysis,
* heart disease or heart failure,
* uncontrolled chronic respiratory disease/ hypertension/ diabetes
* history of
* seizures
* hyperthyroidism
* drug or alcohol abuse
* psychiatric disorder/conditions requiring hospitalization
* chemotherapy/radiation

Where it's running

  • Rutgers School of Dental Medicine
    Newark, New Jersey, United States
    Recruiting

Study contacts

  • Principal investigator: Gayathri D Subramanian, DMD — Rutgers School of Dental Medicine
  • Study coordinator: Gayathri D Subramanian
  • Email: subramga@sdm.rutgers.edu
  • Phone: 9739723418

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.